Results 31 to 40 of about 26,657 (231)

Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection

Emerging Microbes and Infections, 2023
Chronic inflammation and T cell dysregulation persist in individuals infected with human immunodeficiency virus type 1 (HIV-1), even after successful antiretroviral treatment. The mechanism involved is not fully understood. Here, we used Olink proteomics
Lin-Yu Wan, Hui-Huang Huang, Cheng Zhen, Si-Yuan Chen, Bing Song, Wen-Jing Cao, Li-Li Shen, Ming-Ju Zhou, Xiao-Chang Zhang, Ruonan Xu, Xing Fan, Ji-Yuan Zhang, Ming Shi, Chao Zhang, Yan-Mei Jiao, Jin-Wen Song, Fu-Sheng Wang   +16 more
doaj   +1 more source

Evaluation of immunological response to hepatitis B vaccine among healthcare workers at Rwanda Military Hospital

Rwanda Medical Journal, 2023
INTRODUCTION: Healthcare workers (HCWs) are at high risk of acquiring hepatitis B viral (HBV) infection through occupational exposure to blood or body fluids.
C. Muhinda, J. Kabahizi, K. Bazatsinda, N. Dukuze, C. Nsanzabaganwa, G. Murenzi, M. Yotebieng, B. Bagaya, L. Mutesa   +8 more
doaj   +2 more sources

The Immunomodulatory Effects of Artesunate on Immunological Non-responders in Long-term ART-treated People Living with HIV in Selected Provinces in China: A Non-randomized Concurrent Control Trial

Pharmacological Research - Modern Chinese Medicine, 2022
Objective: To investigate the immunomodulatory effects of artesunate in the immunologic non-responders (INRs) in people living with HIV (PLWH), and suggest new adjuvant strategies for HIV treatment in INRs.
Zhuang Tao, Chong Ma, Jipeng Dong, Huijun Guo, Xin Li, Xinghua Tan, Yuqi Yang, Jianping Ma, Shuiqing Liu, Jian Wang, Xiaojie Huang   +10 more
doaj   +1 more source

Eradication of Helicobacter pylori can facilitate immune reconstitution in HIV-1-infected immunological non-responders [PDF]

International Journal of Infectious Diseases, 2010
A significant number of HIV-1 patients experience poor immune reconstitution despite long-term viral suppression with highly active antiretroviral therapy (immunological non-responders). The aims of the present study were to determine whether eradication of Helicobacter pylori could facilitate a better immune reconstitution in these patients.Forty-nine
Magen, Eli, Elbirt, Daniel, Agmon-Levin, Nancy, Mishal, Joseph, Sthoeger, Zev   +4 more
openaire   +2 more sources

Signature genes associated with immunological non-responsiveness to anti-retroviral therapy in HIV-1 subtype-c infection.

PLoS ONE, 2020
ObjectiveHIV-infected individuals undergoing therapy may show an immunological-discordant response to therapy, with poor CD4+ T cells recovery, despite viral suppression below the detection limit.
Sukhvinder Singh, Jaideep S Toor, Aman Sharma, Sunil K Arora   +3 more
doaj   +1 more source

Porcine Reproductive and Respiratory Syndrome virus (PRRSv): A Cross-Sectional Study on ELISA Seronegative, Multivaccinated Sows

Viruses, 2022
Vaccination against Porcine Reproductive and Respiratory Syndrome virus (PRRSv) is widely used to control clinical disease, but the effectiveness appears in some cases to be suboptimal. Field reports have stated the presence of routinely PRRSv-vaccinated
Jorian Fiers, Marylène Tignon, Ann Brigitte Cay, Xavier Simons, Dominiek Maes   +4 more
doaj   +1 more source

Humoral Response to Hepatitis B and COVID-19 Vaccine among Maintenance Hemodialysis Patients

Vaccines, 2022
Maintenance hemodialysis (MHD) patients have impaired immunological responses to pathogens and vaccines. In this study, we compared the humoral response to HBV and COVID-19 vaccines in a cohort of MHD patients. Demographic and clinical characteristics of
Naomi Nacasch, Keren Cohen-Hagai, Nurit Tayar, Avraham Levian, Gloria Rashid, Sydney Benchetrit, Eran Neumark, Ori Wand, Tammy Hod, Yossi Rosman, Moshe Shashar, Ayelet Grupper, Pnina Shitrit   +12 more
doaj   +1 more source

Asymptomatic HIV-Infected Patients Present Blood Parameters Changed, According to Use of Therapy and the CD4+ T Cells Count

Brazilian Journal of Pharmaceutical Sciences, 2022
In HIV-patients, the imbalance in immunological, hematological and biochemical factors can contribute to the progression to AIDS and non-AIDS comorbidities, even during combined antiretroviral therapy (cART).
Karen Ingrid Tasca, Lenice do Rosário de Souza   +1 more
doaj   +1 more source

Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART [PDF]

Journal of the International AIDS Society, 2010
Purpose 15-30% of HAART-treated HIV-1-positive patients (pts) lack CD4+ increase despite full HIV viremia suppression. The increased risk for INR to progress till AIDS led us to investigate maraviroc (MVC) as a tool to intensify HAART in terms of immunological recovery.
S. Rusconi, P. Vitiello, F. Adorni, E. Colella, E. Focà, A. F. Capetti, P. Meraviglia, C. Abeli, S. Bonora, M. D’Annunzio, A. Di Biagio, A. Di Pietro, L. Butini, G. Orofino, S. Farina, G. d’Ettorre, D. Francisci, A. Soria, A. R. Buonomini, C. Tommasi, M. P. Trotta, M. Capasso, E. Merlini, G.C. Marchetti   +23 more
openaire   +2 more sources

An Immunological Non-responder Human Immunodeficiency Virus/Hepatitis C Virus Coinfected Patient: Considerations About a Clinical Case

Cureus, 2023
Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections are two chronic viral infections that share the same mode of transmission, making HIV/HCV coinfection frequent. Highly active antiretroviral therapy (HAART) was a turning point in HIV treatment and has been shown to successfully restore immune function and reduce the frequency of
Soares Correia, Rui, França, Margarida
openaire   +2 more sources